Applied Therapeutics Inc (NASDAQ:APLT)
| 0.9285 BATS BZX Real-Time Price As of 3:09pm ET |  -0.0314 / -3.27%Today’s Change | 0.73 Today|||52-Week Range 19.14 | -89.63% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $54.3M |
Company Description
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.
Contact Information
Applied Therapeutics, Inc. 545 5th Avenue New York New York 10017 |
Employees
Shareholders
| Mutual fund holders | 36.22% |
| Individual stakeholders | 20.40% |
| Other institutional | 10.67% |
Top Executives
| Shoshana Shendelman | Chairman, President, CEO & Secretary |
| Chids Mahadevan | VP-Finance, Chief Financial & Accounting Officer |
| Riccardo Perfetti | Chief Medical Officer |
| Adam Hansard | Chief Commercial Officer |
